Drug, Pharma Benefit Cos. Sued Over Insulin Pricing
Another set of diabetes patients on Wednesday filed a potential class action in New Jersey federal court against Novo Nordisk, Eli Lilly & Co. and Sanofi-Aventis for allegedly conspiring to drive...To view the full article, register now.
Already a subscriber? Click here to view full article